Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson's disease in Taiwan

European Journal of Neurology

Volumn 18, Issue 10, 2011, Pages 1227-1232

  Huang, C L ^a   Wu Chou, Y H ^b,c   Lai, S C ^c   Chang, H C ^c   Yeh, T H ^c   Weng, Y H ^c   Chen, R S ^c   Huang, Y Z ^c   Lu, C S ^c,d  

^a SAINT PAUL S HOSPITAL   (Taiwan)

^b Department of Medical Research ^*  (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

GBA gene; LRRK2; Sporadic Parkinson's disease; Taiwanese

Indexed keywords

CARRIER PROTEIN; GLUCOSYLCERAMIDASE;

ADULT; AGED; ALLELE; ARTICLE; CODING; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; HETEROZYGOSITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARTICIPANT OBSERVATION; PRIORITY JOURNAL; TAIWAN;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSYLCERAMIDASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; TAIWAN; YOUNG ADULT;

EID: 80052800116     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03362.x     Document Type: Article

References (29)

1. Wider C, Foroud T, Wszolek ZK, et al. Clinical implications of gene discovery in Parkinson's disease and parkinsonism. Mov Disord 2010; 25: S15-S20.
2. Rogaeva E, Hardy J. Gaucher and Parkinson diseases: unexpectedly related. Neurology 2008; 70: 2272-2273.
3. Neudorfer O, Giladi N, Elstein D, et al. Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM 1996; 89: 691-694.
4. Neumann J, Bras J, Deas E, et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 2009; 132: 1783-1794.
5. Lesage S, Anheim M, Condroyer C, et al. Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. Hum Mol Genet 2011; 20: 202-210.
6. Ziegler SG, Eblan MJ, Gutti U, et al. Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease. Mol Genet Metab 2007; 91: 195-200.
7. Wu YR, Chen CM, Chao CY, et al. Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese. J Neurol Neurosurg Psychiatry 2007; 78: 977-979.
8. Tan EK, Tong J, Fook-Chong S, et al. Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients. Arch Neurol 2007; 64: 1056-1058.
9. Mitsui J, Mizuta I, Toyoda A, et al. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 2009; 66: 571-576.
10. Mao XY, Burgunder JM, Zhang ZJ, et al. Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China. Neurosci Lett 2010; 469: 256-259.
11. Sun QY, Guo JF, Wang L, et al. Glucocerebrosidase Gene L444P mutation is a risk factor for Parkinson's disease in Chinese population. Mov Disord 2010; 25: 1005-1011.
12. Hu FY, Xi J, Guo J, et al. Association of the glucocerebrosidase N370S allele with Parkinson's disease in two separate Chinese Han populations of mainland China. Eur J Neurol 2010; 17: 1476-1478.
13. Wan L, Hsu CM, Tsai CH, et al. Mutation analysis of Gaucher disease patients in Taiwan: high prevalence of the RecNciI and L444P mutations. Blood Cells Mol Dis 2006; 36: 422-425.
14. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
15. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of Glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009; 361: 1651-1661.
16. Choy FY, Zhang W, Shi HP, et al. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles. Blood Cells Mol Dis 2007; 38: 287-293.
17. Lesage S, Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 2009; 18: R48-R59.
18. Di Fonzo A, Wu-Chou YH, Lu CS, et al. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neuro-genetics 2006; 7: 133-138.
19. Lu CS, Wu-Chou YH, van Doeselaar M, et al. The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population. Neurogenetics 2008; 9: 271-276.
20. Weng YH, Chou YH, Wu WS, et al. PINK1 mutation in Taiwanese early-onset Parkinsonism: clinical, genetic, and dopamine transporter studies. J Neurol 2007; 254: 1347-1355.
21. Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med 2004; 351: 1972-1977.
22. Clark LN, Ross BM, Wang Y, et al. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology 2007; 69: 1270-1277.
23. Sato C, Morgan A, Lang AE, et al. Analysis of the glucocerebrosidase gene in Parkinson's disease. Mov Disord 2005; 20: 367-370.
24. Toft M, Pielsticker L, Ross OA, et al. Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population. Neurology 2006; 66: 415-417.
25. De Marco EV, Annesi G, Quattrone A, et al. Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy. Mov Disord 2008; 23: 460-463.
26. Kalinderi K, Bostantjopoulou S, Fidani L, et al. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Neurosci Lett 2009; 452: 87-89.
27. Gan-Or Z, Bar-Shira A, Mirelman A, et al. LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease. Neurogenetics 2010; 11: 121-125.
28. Aarsland D, Zacczi J, Brayne C. A systemic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005; 20: 1255-1263.
29. Kraoua I, Stirnemann J, Ribeiro MJ, et al. Parkinsonism in Gaucher's disease type I: ten new cases and a review of the literature. Mov Disord 2009; 24: 1524-1530.